Spring Bank Pharmaceuticals raises $10.5mm via Series A; closes round at $22mm
Executive Summary
Spring Bank Pharmaceuticals Inc. (therapeutics for viral infections) raised $10.5mm in its Series A financing led by Brock Securities LLC, which was joined by Gilford Securities.
Deal Industry
- Biotechnology
- Pharmaceuticals
Deal Status
- Final
Deal Type
-
Financing
- Venture Financing
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice